Reports of Rare Body Inflammation After COVID-19 Vaccinations Being Investigated by EU Watchdog

A nurse prepares a Pfizer BioNTech COVID-19 vaccine as part of a vaccine drive by the Fernandeno Tataviam Band of Mission Indians in Arleta, Los Angeles, Calif., on Aug. 23, 2021. (Lucy Nicholson/Reuters)
Share on facebook
Share
Share on twitter
Tweet
Share on whatsapp
WhatsApp
The European Union’s drug regulator said it is reviewing the risk of a body inflammation condition in connection to the Pfizer-BioNTech COVID-19 vaccine. The European Medicines Agency’s safety panel is looking into a report of a 17-year-old male teen from Denmark having developed Multisystem Inflammatory Syndrome (MIS). The teen has fully recovered, the agency said, adding the condition was reported after other COVID-19 vaccines. “MIS is rar
Subscribe or log in to read the rest of this content.

Subscribe for Newsletter

Sign up to receive important news avoided by other media.

Scroll to Top